Gewinn & Umsatz News zur ILLUMINA Aktie

>ILLUMINA Aktienkurs

109.5 EUR +0.1% (TradegateBSX)

Ask: 110.48 EUR / 280 Stück

Bid: 110.26 EUR / 280 Stück

Tagesumsatz: 282 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ILLUMINA Aktie über LYNX handeln

Intraday

1 Jahr

>ILLUMINA Performance

1 Woche: +7,0%

1 Monat: -2,2%

3 Monate: -4,0%

6 Monate: +27,3%

1 Jahr: +57,6%

laufendes Jahr: -4,2%

>ILLUMINA Aktie

Name:

ILLUMINA INC. DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US4523271090 / 927079

Symbol/ Ticker:

ILU (Frankfurt) / ILMN (NASDAQ)

Kürzel:

FRA:ILU, ETR:ILU, ILU:GR, NASDAQ:ILMN

Index:

S&P500

Webseite:

http://www.illumina.com/

Profil:

Illumina, Inc. develops, manufactures, and markets sequencing- and array-based solutions for genetic and genomic analysis worldwide, including in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company provides..
>Volltext..

Marktkapitalisierung:

16773.35 Mio. EUR

Unternehmenswert:

17556.3 Mio. EUR

Umsatz:

3760.67 Mio. EUR

EBITDA:

1009.26 Mio. EUR

Nettogewinn:

736.37 Mio. EUR

Gewinn je Aktie:

4.75 EUR

Schulden:

2211.7 Mio. EUR

Liquide Mittel:

1228.43 Mio. EUR

Operativer Cashflow:

934.75 Mio. EUR

Bargeldquote:

1.03

Umsatzwachstum:

-12.48%

Gewinnwachstum:

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

ILLUMINA

Letzte Datenerhebung:

05.04.26

>ILLUMINA Kennzahlen

Aktien/ Unternehmen:

Aktien: 152.9 Mio. St.

Frei handelbar: 97.19%

Leerverk. Aktien: 4.73%

Rückkaufquote: 3.61%

Mitarbeiter: 8600

Umsatz/Mitarb.: 0.44 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 7.83%

Bewertung:

KGV: 23.49

KGV lG: 24.57

KUV: 4.46

KBV: 7.21

PEG-Ratio: -

EV/EBITDA: 17.4

Rentabilität:

Bruttomarge: 67.08%

Gewinnmarge: 19.58%

Operative Marge: 20.59%

Managementeffizenz:

Gesamtkaprendite: 13.13%

Eigenkaprendite: 33.36%

>ILLUMINA Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege

>ILLUMINA Chart & Kurs - NASDAQ

>ILLUMINA Gewinn & Umsatz News

05.02.26 - 23:12	Illumina Inc. Q4 Profit Advances (AFX)
	SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) released earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line came in at $334 million, or $2.16 per sh......

13.01.26 - 16:12	Illumina Preliminary Q4, Annual Results Beat Analysts′ View (AFX)
	SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN), a biotechnology company, on Tuesday reported preliminary results for the fourth quarter and fiscal 2025 above analysts' expectations.For the fourth qua......

31.10.25 - 19:25	OPEC+ Balances Oil Risks from Sanctions, Illumina 3Q Beats Estimates \| Bloomberg Markets 10/31/2025 (Bloomberg)
	"Bloomberg Markets" follows the market moves across every global asset class and discusses the biggest issues for Wall Street. Today's guests: Illumina CEO Jacob Thaysen, Bloomberg's Simon Casey and Justin Fox. (Source: Bloomberg)...

30.10.25 - 22:06	Illumina Inc. Q3 Profit Decreases, But Beats Estimates (AFX)
	SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) revealed a profit for third quarter that Decreased from the same period last year but beat the Street estimates.The company's bottom line came in at $150......

15.05.25 - 18:18

Quantum-Si (QSI) Earnings Coverage: Complete 1Q Coverage (24/7 Wall St.)

Live Updates Live Coverage Updates appear automatically as they are published. QSI Earnings Backdrop 11:26 am Quantum-Si operates at the intersection of biotech instrumentation and proteomics, targeting academic and pharma customers with novel single-molecule protein sequencing tech. The industry has seen strong interest in next-gen diagnostic platforms, but commercial adoption remains slow. Illumina's recent restructuring […] The post Quantum-Si (QSI) Earnings Coverage: Complete 1Q Coverage appeared first on 24/7 Wall St.....

10.03.25 - 23:12	Illumina Lowers FY25 Outlook Hurt By China Sales Ban (AFX)
	SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN) responded on Monday to the notice from the China Ministry of Commerce stating that it is not permitted to export sequencing instruments into China. Illu......

10.03.25 - 21:06	Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban (WSJ EN)
	Beijing banned imports of Illumina's gene-sequencing machines in response to U.S. tariffs....

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram